Glen Eagle Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$347K Hold
856
0.05% 196
2025
Q1
$426K Sell
856
-10
-1% -$4.98K 0.07% 152
2024
Q4
$451K Sell
866
-12
-1% -$6.24K 0.07% 150
2024
Q3
$543K Sell
878
-7
-0.8% -$4.33K 0.09% 140
2024
Q2
$489K Sell
885
-33
-4% -$18.2K 0.09% 139
2024
Q1
$534K Sell
918
-65
-7% -$37.8K 0.1% 139
2023
Q4
$522K Sell
983
-115
-10% -$61K 0.11% 137
2023
Q3
$556K Sell
1,098
-66
-6% -$33.4K 0.13% 121
2023
Q2
$607K Sell
1,164
-3
-0.3% -$1.56K 0.14% 123
2023
Q1
$673K Buy
1,167
+5
+0.4% +$2.88K 0.17% 110
2022
Q4
$640K Buy
1,162
+34
+3% +$18.7K 0.17% 108
2022
Q3
$572K Sell
1,128
-5
-0.4% -$2.54K 0.17% 113
2022
Q2
$616K Sell
1,133
-5
-0.4% -$2.72K 0.17% 112
2022
Q1
$672K Sell
1,138
-45
-4% -$26.6K 0.18% 119
2021
Q4
$789K Hold
1,183
0.21% 108
2021
Q3
$676K Sell
1,183
-15
-1% -$8.57K 0.2% 115
2021
Q2
$604K Sell
1,198
-34
-3% -$17.2K 0.19% 115
2021
Q1
$562K Sell
1,232
-25
-2% -$11.4K 0.2% 110
2020
Q4
$585K Sell
1,257
-16
-1% -$7.45K 0.23% 92
2020
Q3
$562K Sell
1,273
-29
-2% -$12.8K 0.25% 86
2020
Q2
$472K Buy
1,302
+10
+0.8% +$3.62K 0.24% 90
2020
Q1
$366K Hold
1,292
0.26% 93
2019
Q4
$420K Hold
1,292
0.22% 96
2019
Q3
$376K Hold
1,292
0.25% 90
2019
Q2
$379K Hold
1,292
0.26% 89
2019
Q1
$354K Sell
1,292
-20
-2% -$5.47K 0.26% 88
2018
Q4
$294K Hold
1,312
0.25% 89
2018
Q3
$320K Buy
1,312
+20
+2% +$4.88K 0.23% 96
2018
Q2
$268K Hold
1,292
0.21% 106
2018
Q1
$267K Hold
1,292
0.22% 104
2017
Q4
$245K Hold
1,292
0.21% 114
2017
Q3
$244K Sell
1,292
-1,290
-50% -$244K 0.23% 108
2017
Q2
$450K Hold
2,582
0.36% 73
2017
Q1
$397K Hold
2,582
0.34% 78
2016
Q4
$364K Buy
+2,582
New +$364K 0.33% 83